Literature DB >> 1553572

Therapeutic alternatives in clinical stage I nonseminomatous disease.

M Rørth1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1553572

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

1.  [Testicular tumor--yesterday--today--tomorrow].

Authors:  S Krege; C Wittekind; R Souchon; F Honecker; C Bokemeyer; P Albers; J Gschwend; H Rübben
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

2.  The difficulty defining "benefit" of new antineoplastic strategies.

Authors:  M Markman
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

3.  Is modified retroperitoneal lymph node dissection (MRLND) still feasible in the treatment of patients with clinical stage I non-seminomatous testicular cancer?

Authors:  M Sosnowski; L Jeromin; A Płuzańska
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.